Odile Bain Memorial Prize 2021 Odile Bain Memorial Prize 2021 Brilliant early-career scientists in parasitology recognized
Our partners Bioveta Our partners Bioveta Our partner Bioveta shares insights about the longstanding collaboration with Boehringer Ingelheim and the evolution of the partnership
Human-dog relationship – a historical perspective Human-dog relationship – a historical perspective The human-dog relationship – a historical perspective
All hands-on deck to fight the ‘zombie’ rabies virus All hands-on deck to fight the ‘zombie’ rabies virus We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships.
How dangerous is the mpox virus? How dangerous is the mpox virus? Mpox, formerly known as monkeypox: What exactly is this virus, how is it transmitted, and what are the most noticeable symptoms?
EFPIA disclosure EFPIA disclosure Disclosure of Boehringer Ingelheim affiliates in countries with EFPIA member associations.
Improving Access to Stroke Care Improving Access to Stroke Care Angels Initiative named Best Practice example by the Access to Medicine Index
The Supplier Code of Conduct Download The Supplier Code of Conduct Download Our Values - Your Values. Download the Supplier Code of Conduct.
Where to meet us Where to meet us Find out where to meet the BD&L team virtually or in person at the next conference or event. Submit your opportunity to our BD&L team here.
Equestrian sports horse health awareness Alex Hua Tian Equestrian sports horse health awareness Alex Hua Tian Together with Olympian trailblazer and eventer Alex Hua Tian, we educate about equine health in China.
Boehringer Ingelheim good 2021 business performance Boehringer Ingelheim good 2021 business performance 2021 was a good year for patients, for animal owners and for Boehringer Ingelheim.
2020-Positive-business-momentum-despite-COVID-19-impact 2020-Positive-business-momentum-despite-COVID-19-impact While stepping up its investments in R&D significantly, Boehringer Ingelheim achieved a solid business performance in 2020 despite the COVID-19 pandemic.